ArticleOman medical journal2025
Annual Trend in Hypoglycemia Emergency Cases in Oman: A Single Center Retrospective Study.
Article in Oman medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to estimate the incidence and trends of hypoglycemia cases admitted to the emergency department of a tertiary hospital in Oman before the COVID-19 pandemic. Methods: We retrospectively reviewed the hospital records of all patients aged ≥ 15 years admitted to the emergency department with hypoglycemia (random blood glucose level ≤ 3.9 mmol/L) between January 2010 and January 2017. Results: A total of 242 patients were admitted with hypoglycemia, with an incidence increasing from 3.31 to 5.25 per 10 000 individuals during the study period. Non-diabetic patients exhibited significantly higher rates of abnormal heart rates compared to those with diabetes ( Conclusions: The incidence of hypoglycemia presentations increased during the study period. Intravenous dextrose was the primary management approach for diabetic patients, and glucagon use was minimal. Further investigation is required to decipher the hypoglycemia trends in the post-pandemic period.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.